| Serum microRNA-371a-3p levels predict viable germ cell tumor in chemotherapy-naïve patients undergoing retroperitoneal lymph node dissection JT Lafin, N Singla, SL Woldu, Y Lotan, CM Lewis, K Majmudar, ... European urology 77 (2), 290, 2020 | 56 | 2020 |
| Real-world application of pre-orchiectomy miR-371a-3p test in testicular germ cell tumor management RR Badia, D Abe, D Wong, N Singla, A Savelyeva, N Chertack, SL Woldu, ... The Journal of urology 205 (1), 137-144, 2021 | 43 | 2021 |
| Serum small RNA sequencing and miR-375 assay do not identify the presence of pure teratoma at postchemotherapy retroperitoneal lymph node dissection JT Lafin, AP Kenigsberg, X Meng, D Abe, A Savelyeva, N Singla, ... European urology open science 26, 83-87, 2021 | 31 | 2021 |
| New insights into germ cell tumor genomics JT Lafin, A Bagrodia, S Woldu, JF Amatruda Andrology 7 (4), 507-515, 2019 | 30 | 2019 |
| MicroRNAs: Turning the Tide in Testicular Cancer. N Singla, JT Lafin, A Bagrodia European urology 76 (5), 541-542, 2019 | 27 | 2019 |
| A multi-institutional pooled analysis demonstrates that circulating miR-371a-3p alone is sufficient for testicular malignant germ cell tumor diagnosis J Piao, JT Lafin, CG Scarpini, MM Nuño, I Syring, KP Dieckmann, G Belge, ... Clinical genitourinary cancer 19 (6), 469-479, 2021 | 23 | 2021 |
| Hydroxytyrosol inhibits chemokine CC motif ligand 5 mediated aged quiescent fibroblast-induced stimulation of breast cancer cell proliferation EH Sarsour, M Goswami, AL Kalen, JT Lafin, PC Goswami Age 36, 1213-1224, 2014 | 21 | 2014 |
| Impact of circulating microRNA test (miRNA‐371a‐3p) on appropriateness of treatment and cost outcomes in patients with Stage I non‐seminomatous germ cell tumours A Bagrodia, A Savelyeva, JT Lafin, RW Speir, GT Chesnut, AL Frazier, ... BJU international 128 (1), 57-64, 2021 | 17 | 2021 |
| Methylseleninic acid induces lipid peroxidation and radiation sensitivity in head and neck cancer cells JT Lafin, EH Sarsour, AL Kalen, BA Wagner, GR Buettner, PC Goswami International journal of molecular sciences 20 (1), 225, 2019 | 16 | 2019 |
| Genetics of testicular germ cell tumors N Singla, JT Lafin, RA Ghandour, S Kaffenberger, JF Amatruda, ... Current opinion in urology 29 (4), 344-349, 2019 | 13 | 2019 |
| The road ahead for circulating microRNAs in diagnosis and management of testicular germ cell tumors JT Lafin, MJ Murray, N Coleman, AL Frazier, JF Amatruda, A Bagrodia Molecular Diagnosis & Therapy 25 (3), 269-271, 2021 | 10 | 2021 |
| Evaluation of miR‐371a‐3p to predict viable germ cell tumor in patients with pure seminoma receiving retroperitoneal lymph node dissection B Konneh, JT Lafin, J Howard, T Gerald, A Amini, A Savelyeva, SL Woldu, ... Andrology 11 (4), 634-640, 2023 | 8 | 2023 |
| PD19-09 Predictive capacity of miRNA-375 in identifying teratoma in post-chemotherapy retroperitoneal lymph node dissection (PC-RPLND) A Kenigsberg, J Lafin, X Meng, D Abe, A Savalyeva, N Singla, S Woldu, ... Journal of Urology 203, e385, 2020 | 8 | 2020 |
| Refining the serum miR-371a-3p test for viable germ cell tumor detection JT Lafin, CG Scarpini, A Amini, B Konneh, JM Howard, T Gerald, M Nuno, ... Scientific reports 13 (1), 10558, 2023 | 6 | 2023 |
| Identification of testicular cancer driver genes by a cross‐species comparative oncology approach A Sanchez, L Xu, JL Pierce, JT Lafin, D Abe, A Bagrodia, AL Frazier, ... Andrology 7 (4), 545-554, 2019 | 4 | 2019 |
| Management of Testicular Germ Cell Tumor With Somatic-Type Malignancy. B Konneh, AJ Leonard, JT Lafin, L Jia, A Bagrodia Oncology (Williston Park, NY) 36 (6), 375-377, 2022 | 2 | 2022 |
| Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5‐alpha reductase inhibitor resistance R Jin, CM Forbes, NL Miller, J Lafin, DW Strand, T Case, JM Cates, Q Liu, ... The Prostate, 2024 | 1 | 2024 |
| AGCT1531: Evaluating the utility of circulating microRNA in the management of children, adolescents, and adults with malignant germ cell tumors. F Shaikh, A Bagrodia, JF Amatruda, M Nuno, M Murray, N Coleman, ... Journal of Clinical Oncology 41 (16_suppl), TPS5104-TPS5104, 2023 | 1 | 2023 |
| The genomic and transcriptomic landscapes of chemotherapy naïve vs post-chemotherapy germ cell tumors. A Bagrodia, Y Sawa, L Jia, HB Krause, F Millard, AP Farrell, A Elliott, ... Journal of Clinical Oncology 41 (16_suppl), 5007-5007, 2023 | 1 | 2023 |
| Refining the serum miR-371a-3p test for viable germ cell tumor detection: identification and definition of an indeterminate range J Lafin, C Scarpini, A Amini, B Konneh, J Howard, T Gerald, M Nuno, ... Research Square, 2023 | 1 | 2023 |
